MannKind Halted News Pending
It looks like we’ll finally have a decision on the status of Afrezza® as shares of MannKind (NASDAQ:MNKD) have been halted with “news” pending. Prior to this halt shares had plunged nearly 40% and trading was heavy. Although Diabetic Investor has no idea what the decision is, we do believe that had the FDA decided in the affirmative this news would be released immediately.
Sources are telling Diabetic Investor that whatever the news is it will come after the market closes at 4pm EST.
At this point no one at the company is talking and all the FDA press office will say is that if we want to know what’s going on call the company. This cryptic statement leads Diabetic Investor to believe the FDA has informed the company of their decision, who must now release it to the public.
Again Diabetic Investor wants to reiterate we have no idea what the decision is however given the preponderance of evidence we don’t believe that good news is coming. Stay Tuned!